Gene · 3003
Papers2,892
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 2,892
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Central Diabetes Insipidus: An Acute Manifestation of COVID-19 Infection. | Cureus | 2023 | 37746393 | PubTator, text mining | PubMed |
| Unveiling novel insights in prostate cancer through single-cell RNA sequencing. | Front Oncol | 2023 | 37746302 | PubTator, text mining | PubMed |
| Recent advances and future perspectives in the therapeutics of prostate cancer. | Exp Hematol Oncol | 2023 | 37740236 | PubTator, text mining | PubMed |
| Multi-omics indicators of long-term survival benefits after immune checkpoint inhibitor therapy. | Cell Rep Methods | 2023 | 37738982 | PubTator, text mining | PubMed |
| Dynamic single-cell mapping unveils Epstein‒Barr virus-imprinted T-cell exhaustion and on-treatment response. | Signal Transduct Target Ther | 2023 | 37735150 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing shows the immune cell landscape in the kidneys of patients with idiopathic membranous nephropathy. | Front Immunol | 2023 | 37731504 | PubTator, text mining | PubMed |
| Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance. | Nat Commun | 2023 | 37730678 | PubTator, text mining | PubMed |
| A 12-gene panel in estimating hormone-treatment responses of castration-resistant prostate cancer patients generated using a combined analysis of bulk and single-cell sequencing data. | Ann Med | 2023 | 37729607 | PubTator, text mining | PubMed |
| The bladder cancer immune micro-environment in the context of response to immune checkpoint inhibition. | Front Immunol | 2023 | 37727793 | PubTator, text mining | PubMed |
| Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer. | JAMA Netw Open | 2023 | 37721753 | PubTator, text mining | PubMed |
| Autoimmune uveitis in Behçet's disease and Vogt-Koyanagi-Harada disease differ in tissue immune infiltration and T cell clonality. | Clin Transl Immunology | 2023 | 37720629 | PubTator, text mining | PubMed |
| TCM "medicine and food homology" in the management of post-COVID disorders. | Front Immunol | 2023 | 37720220 | PubTator, text mining | PubMed |
| Polygenic regression uncovers trait-relevant cellular contexts through pathway activation transformation of single-cell RNA sequencing data. | Cell Genom | 2023 | 37719150 | PubTator, text mining | PubMed |
| Performance of tumour microenvironment deconvolution methods in breast cancer using single-cell simulated bulk mixtures. | Nat Commun | 2023 | 37717006 | PubTator, text mining | PubMed |
| Association of immune-related expression profile with sensitivity to chemotherapy in esophageal squamous cell carcinoma. | Cancer Sci | 2023 | 37715346 | PubTator, text mining | PubMed |
| Conserved γδ T cell selection by BTNL proteins limits progression of human inflammatory bowel disease. | Science | 2023 | 37708268 | PubTator, text mining | PubMed |
| Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial. | Cancer Discov | 2023 | 37707791 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing of Coronary Perivascular Adipose Tissue From End-Stage Heart Failure Patients Identifies SPP1+ Macrophage Subpopulation as a Target for Alleviating Fibrosis. | Arterioscler Thromb Vasc Biol | 2023 | 37706320 | PubTator, text mining | PubMed |
| Challenges of clinical translation from single-cell sequencing to measures in clinical biochemistry of haematology: Definition of immune cell identities. | Clin Transl Med | 2023 | 37700496 | PubTator, text mining | PubMed |
| Mild/asymptomatic COVID-19 in unvaccinated pregnant mothers impairs neonatal immune responses. | JCI Insight | 2023 | 37698937 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/papers?page=25